Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompass Group Regulatory News (CPG)

Share Price Information for Compass Group (CPG)

Share Price is delayed by 15 minutes
Get Live Data
33.38    0.40 (1.21%)
Bid:
33.37
Ask:
33.39
Spread: 0.02 (0.06%)
Market Cap: $56.76b
CPG Live PriceLast checked at - London Stock Exchange

Intraday Compass Group Share Chart

Trading Statement

6 Feb 2025 07:00

RNS Number : 0721W
Compass Group PLC
06 February 2025
 
Legal Entity Identifier (LEI) No. 2138008M6MH9OZ6U2T68
 

 

6 February 2025 - Compass Group PLC, a global leader in food services, today announces trading results for the first quarter ended 31 December 2024. The statement is being issued ahead of the Company's Annual General Meeting which will be held at 12 noon today at Allianz Stadium (formerly Twickenham Stadium).

 

Strong start to the year - continued growth momentum

The Group delivered strong organic revenue growth of 9.2% in the first quarter. All regions and sectors performed well, with positive outsourcing trends continuing to underpin our growth momentum. Organic growth drivers were in line with our expectations, with net new business supported by strong client retention, and pricing and volumes trending as anticipated. 

 

Organic revenue growth1

Group

North America

Europe

Rest of

World

Q1 2025

9.2%

9.7%

8.4%

7.9%

 

We continue to invest in attractive growth opportunities which further enhance our sectorisation and capabilities to unlock new market opportunities.

 

The Group's expenditure on M&A for the year to date is c.$1.0bn, the majority relating to Dupont Restauration (France) and 4Service (Norway), which completed in January, alongside the disposals of our operations in Chile and Kazakhstan.

 

Currency

 

If current spot rates were to continue for the remainder of the year, foreign exchange translation would negatively impact 2024 revenue by $558 million2 and operating profit by $36 million2.

 

Summary and guidance

 

We are pleased with the strong start to the year. The Group delivered good growth across all regions and sectors, supported by continued strong client retention.

 

We are an even more focused business and are leveraging investments in capex and M&A to support future growth, as we maintain our strong track record of delivering long-term, compounding shareholder returns.

 

Our 2025 guidance remains unchanged. We expect to deliver high single digit underlying operating profit growth3 with organic revenue growth above 7.5% and ongoing margin progression. 

 

1 Year on year change.

2 Based on spot rates as of 31st January 2025.

3 On a constant-currency basis, including announced acquisitions, disposals and exits in 2024 and to date in 2025.

Change to segmental reporting post portfolio reshaping

 

Our Rest of World region now accounts for c.5% of the Group's revenue on a pro forma basis. As a result, the Group's internal management reporting structure has been changed to combine Rest of World with Europe to form a new International region. 

 

From our Half Year results in May 2025 we will therefore report regional results for North America and International. Restated financial information will be provided in March.

 

Conference call

There will be a live Q&A session for sell-side analysts at 9.00am. Please connect to the call at least 10 minutes prior to the start time by dialling:

UK Toll Number: 

+44 (0) 33 0551 0200

UK Toll-Free Number: 

0808 109 0700 

New York Number: 

+1 786 697 3501

US Toll-Free Number: 

866 580 3963

Please reference COMPASS  

 

Financial calendar

Payment date for 2024 final dividend

Half year results

27 February 2025

14 May 2025

Q3 trading update

Full year results

22 July 2025

25 November 2025

 

 

Enquiries

 

Investors

Agatha Donnelly, Helen Javanshiri,Simon Bielecki

 

+44 1932 573 000

Press

Amy Shields, Compass Group

Tim Danaher, Brunswick

 

+44 1932 573 000

+44 207 404 5959

Website

www.compass-group.com

Forward-looking statements

Certain information included in this Announcement is forward looking and involves risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied by forward-looking statements. Forward-looking statements cover all matters which are not historical facts and include, without limitation, the direct and indirect future impacts and implications of: public health crises such as the coronavirus COVID-19 on the economy, nationally and internationally, and on the Group, its operations and prospects; risks associated with changes in environmental scenarios and related regulations including (without limitation) the evolution and development of the global transition to a low carbon economy (including increasing societal and investor expectations); disruptions and inefficiencies in supply chains (such as resulting from the wars in Ukraine and the Middle East); future domestic and global political, economic and business conditions (such as inflation or the UK's exit from the EU); projections relating to results of operations and financial conditions and the Company's plans and objectives for future operations, including, without limitation, discussions of expected future revenues, financing plans and expected expenditures and divestments; risks associated with changes in economic conditions, levels of economic growth and the strength of the food and support services markets in the jurisdictions in which the Group operates; fluctuations in food and other product costs and labour costs; prices and changes in exchange and interest rates; and the impacts of technological advancements.

Forward looking statements can be identified by the use of forward-looking terminology, including terms such as 'believes', 'estimates', 'anticipates', 'expects', 'forecasts', 'intends', 'plans', 'projects', 'goal', 'target', 'aim', 'may', 'will', 'would', 'could' or 'should' or, in each case, their negative or other variations or comparable terminology. Forward-looking statements Forward-looking statements in this Announcement are not guarantees of future performance. All forward-looking statements in this Announcement are based upon information known to the Company on the date of this Announcement. Accordingly, no assurance can be given that any particular expectation will be met and readers are cautioned not to place undue reliance on forward-looking statements when making their investment decisions. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation or warranty that such trends or activities will continue in the future. Other than in accordance with its legal or regulatory obligations (including under the UK Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority), the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Nothing in this Announcement shall exclude any liability under applicable laws that cannot be excluded in accordance with such laws.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFERFIIEIIE
Date   Source Headline
30th Nov 20175:30 pmRNSTotal Voting Rights
28th Nov 20175:55 pmRNSDirector/PDMR Shareholding
24th Nov 20174:26 pmRNSDirector/PDMR Shareholding
24th Nov 20179:00 amRNSDirector/PDMR Shareholding
21st Nov 20178:32 amRNSFull year results - year ended 30 Sept 17
21st Nov 20177:00 amRNSFull year results for year ended 30 Sept 2017
31st Oct 20176:27 pmRNSTotal Voting Rights
9th Oct 20172:48 pmRNSDirector/PDMR Shareholding
9th Oct 20171:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20179:00 amRNSTotal Voting Rights
2nd Oct 20177:00 amRNSBlock listing Interim Review
21st Sep 20177:00 amRNSCompass Group PLC CEO Succession
1st Sep 20178:00 amRNSTotal Voting Rights
1st Aug 20178:00 amRNSTotal Voting Rights
26th Jul 20177:00 amRNSThird Quarter Update
19th Jul 20177:00 amRNSDirector/PDMR Shareholding
17th Jul 201710:39 amRNSPayment of Special Dividend of c.£1 billion
3rd Jul 20177:00 amRNSTotal Voting Rights
27th Jun 20177:00 amRNSShare Capital Consolidation and Admission
26th Jun 20176:05 pmRNSCorrection of ISIN and Common codes EMTN Programme
26th Jun 20176:00 pmRNSCorrection of ISIN and Common codes EMTN Programme
21st Jun 20175:18 pmRNSEuro Medium Term Note Programme - Final Terms
20th Jun 201711:24 amRNSDirector/PDMR Shareholding
14th Jun 201711:49 amRNSTransaction in Own Shares
8th Jun 20177:00 amRNSUpdate relating to Shareholder Return
8th Jun 20177:00 amRNSResult of General Meeting
1st Jun 20179:53 amRNSUpdate of Euro Medium Term Note Programme
1st Jun 20177:00 amRNSTotal Voting Rights
15th May 201712:03 pmRNSShareholder Return and Notice of General Meeting
11th May 20179:51 amRNSDirector/PDMR Shareholding
10th May 20177:00 amRNSHalf year results announcement
2nd May 20179:00 amRNSTotal Voting Rights
21st Apr 20175:04 pmRNSTransaction in Own Shares
20th Apr 20174:53 pmRNSTransaction in Own Shares
19th Apr 20174:59 pmRNSTransaction in Own Shares
7th Apr 20175:07 pmRNSTransaction in Own Shares
6th Apr 20175:00 pmRNSTransaction in Own Shares
5th Apr 20175:00 pmRNSTransaction in Own Shares
4th Apr 20175:15 pmRNSTransaction in Own Shares
3rd Apr 20175:00 pmRNSTransaction in Own Shares
3rd Apr 20179:00 amRNSTotal Voting Rights
31st Mar 20175:43 pmRNSTransaction in Own Shares
31st Mar 201710:00 amRNSBlock listing Interim Review
30th Mar 20174:51 pmRNSTransaction in Own Shares
29th Mar 20175:06 pmRNSTransaction in Own Shares
28th Mar 20175:56 pmRNSTransaction in Own Shares
27th Mar 20174:53 pmRNSTransaction in Own Shares
24th Mar 20175:11 pmRNSTransaction in Own Shares
23rd Mar 20174:53 pmRNSTransaction in Own Shares
22nd Mar 20174:43 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.